Find four things in writing before paying: how the plan ends, how much notice ends it, what happens to money already paid, and whether anything is refundable after a prescription has been filled. A published, workable exit is one of the clearest legitimacy signals in cash-pay telehealth. Its absence is a structural warning, and it is easy to check in a few minutes.
Exit terms as a legitimacy test
Reviewers tend to treat cancellation policy as a customer service topic. It is better read as a compliance one. Federal law governing online negative option offers requires clear disclosure of the terms before a charge, informed consent to those terms, and a simple mechanism to stop recurring charges. Many state automatic renewal statutes add their own disclosure and cancellation requirements on top.
That reframes the question. A program that hides its exit is not merely irritating, it is operating against a rule that already applies to it. A program that publishes renewal date, notice period and refund treatment on the plan selection page is showing something checkable. Medvi and its competitors should all be assessed on that basis rather than on how generous the policy sounds.
Where a program keeps this information matters as much as the wording. A provider such as HealthRX presents its GLP-1 medications alongside the renewal and cancellation terms that govern them, which is easier to verify than a policy filed several clicks away, and the same spread shows up across Ro, Hims and Hers, and Henry Meds. The reliable move is to read the live terms on whichever provider is under consideration rather than to trust a figure quoted secondhand.
The four clauses that decide almost every dispute
The first is the renewal trigger. Charges in this market are often tied to a fill and ship cycle rather than a calendar month, so the billing date drifts from the enrollment date. Anyone assuming a clean monthly anniversary will eventually be surprised by timing.
The second is the notice window. Where a program requires a request some days ahead of processing, a late request ends the plan after one more charge instead of immediately. The third is the treatment of prepaid months on a multi-month plan. The fourth is the post-dispense rule, which nearly always excludes medication that has already left the pharmacy.
| Clause | What it controls | Where it is usually published |
|---|---|---|
| Renewal trigger | Whether billing follows a date or a fill cycle | Subscription terms, order confirmation |
| Notice period | Whether one further charge posts after a request | Terms of service, cancellation section |
| Prepaid plan treatment | Value of unshipped months on early exit | Plan selection page, checkout terms |
| Post-dispense refunds | Almost always excludes shipped medication | Refund or returns policy |
| Required exit channel | Whether a request counts as valid notice | Account settings, terms of service |
| Declined intake handling | What happens if the clinician says no | Checkout page, intake flow |
Why shipped medication is not returnable
This is pharmacy law rather than company preference. Once a dispensed drug leaves professional custody, storage conditions and handling can no longer be verified, so it cannot lawfully be restocked and given to another patient. Injectables that require refrigeration make the point sharper, since a temperature excursion in transit or at home cannot be ruled out afterward.
A refund granted after shipment is therefore a goodwill credit, not a return. Programs that offer one are being generous. Treating that generosity as an entitlement is where a lot of disappointment starts, and it is another reason the renewal date matters more than the refund policy does.
Reading comparison pages on exit terms
Terms language varies far more between cash-pay programs than the medication does, which makes it a genuine differentiator. Some publish the full policy where the plan is chosen. Others place it behind a link most people scroll past. Both are lawful and only one is helpful.
Round-ups that collect this material save time, with one caveat: many are written by rivals. A Medvi write-up of that kind is published by the provider behind it, a competing cash-pay program, so it is best used for the checklist it produces rather than the conclusion it reaches. Terms also change without notice, which is why the live policy page beats any summary of it.
Stopping treatment is a clinical decision as well as a billing one
Ending a subscription ends supply, and supply interruption has a documented effect. The extension analysis of the semaglutide registration trial found participants regained a large share of lost weight in the year after withdrawal, and a maintenance trial found that switching to placebo after titration reversed progress while continued treatment produced further reduction. Later reviews describe the same pattern across the drug class.
That argues for planning the exit rather than triggering it in frustration over a charge. A patient who intends to continue with a different provider should overlap the handover so an escalation schedule is not interrupted. Compounded preparations are not FDA-approved, and the absence of an approved label makes prescriber involvement in stopping and restarting more important rather than less.
Frequently asked questions
What paperwork should be kept?
The timestamped confirmation of the cancellation request, any ticket or case number, and the text of what was sent. That record resolves most billing disagreements directly with the provider. It is also the first thing a card issuer asks for if the matter escalates to a dispute, so saving it costs nothing and settles a lot.
Is a chargeback the right first move?
Usually not. Contacting the provider through the channel named in the terms is faster and preserves the account. Filing a dispute first often freezes the account and slows resolution. If the provider does not respond within a reasonable window, the saved documentation is what makes a later dispute straightforward.
Do prepaid discount plans block cancellation?
No, but they change what cancellation is worth. Stopping future renewals is generally straightforward. Whether already-paid months are refunded, prorated at the discounted rate, prorated at the standard rate, or forfeited depends entirely on the clause. All four approaches exist in this market and all are disclosed somewhere.
Does a hard-to-find cancellation route mean a provider is illegitimate?
Not on its own, though it is a fair complaint and may conflict with disclosure rules. The stronger structural signals are no named prescriber, no named pharmacy, no published terms at all, or a claim that a compounded product is FDA-approved. Weigh those before drawing conclusions from friction alone.
What happens if the clinician declines the intake?
That should be answered on the checkout page. Some programs authorize payment and release it if the request is turned down, others charge only after approval. Both models are used. The point worth settling in advance is where the money sits during review and how quickly it comes back.
